In another study, Wong et al. have concluded that the presence of coexisting DCIS in IDC predicts lower biological aggressiveness in luminal cancers but not in the conventionally more aggressive HER2-positive and triple-negative subtypes (10). Here, ERBB2 is linked to ductal breast carcinoma in situ.